4//SEC Filing
Shah Preetam 4
Accession 0001610618-21-000082
CIK 0001610618other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:32 PM ET
Size
7.8 KB
Accession
0001610618-21-000082
Insider Transaction Report
Form 4
Shah Preetam
CFO & CBO
Transactions
- Award
Restricted Stock Unit
2021-09-01+50,000→ 50,000 totalExp: 2022-09-30→ Common Stock (50,000 underlying) - Award
Stock Option (right to buy)
2021-09-01+311,850→ 311,850 totalExercise: $2.22Exp: 2031-08-31→ Common Stock (311,850 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of September 1, 2021; 1/48th of the shares subject to the option shall vest monthly thereafter,such that all shares will be vested on September 1, 2025.
- [F2]Restricted stock units convert into common stock on a one-for-one basis.
- [F3]The RSU will fully vest upon the completion of certain corporate milestones on or before September 30, 2022.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001787403
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 4:32 PM ET
- Size
- 7.8 KB